2629 Share Price Performance
HK$13.06
-16.94 (-56.47%)
Price HK$13.06
Share Pricen/a
Mirxes Holding Company Limited Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 1 Fair Values set on narratives written by author
2629 Community Narratives
There are no narratives available yet.
There are no community narratives available.
Trending Discussion
Recently Updated Narratives
No recently updated narratives available.
Snowflake Analysis
Mirxes Holding Company Limited Key Details
Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
Mar 31, 2026
- -0.26
- 53.45%
- -359.78%
- 13.4%
About 2629
- Founded
- 2014
- Employees
- 347
- CEO
- WebsiteView website
Mirxes Holding Company Limited, a micro ribonucleic acid technology company, provides diagnostic solutions for the screening of cancer, cardiovascular, metabolic, and infectious diseases accessible across Singapore and China. The company offers GASTROClear, a blood-based miRNA detection panel consisting of 12 miRNA biomarkers for gastric cancer screening; LUNGClear, a lung cancer screening product candidate; and Fortitude COVID-19 RT-qPCR test kits. It also researches, develops, and manufactures biotechnology, life, and medical science related products. The company was founded in 2014 and is headquartered in Singapore.
